239 related articles for article (PubMed ID: 33017199)
1. Modeling drug transport within the viable skin - a review.
Calcutt JJ; Roberts MS; Anissimov YG
Expert Opin Drug Metab Toxicol; 2021 Jan; 17(1):105-119. PubMed ID: 33017199
[TBL] [Abstract][Full Text] [Related]
2. Breaking the skin barrier: achievements and future directions.
Zhang H; Zhai Y; Yang X; Zhai G
Curr Pharm Des; 2015; 21(20):2713-24. PubMed ID: 25925124
[TBL] [Abstract][Full Text] [Related]
3. Transdermal iontophoretic drug delivery: advances and challenges.
Ita K
J Drug Target; 2016; 24(5):386-91. PubMed ID: 26406291
[TBL] [Abstract][Full Text] [Related]
4. Mathematical models to describe iontophoretic transport in vitro and in vivo and the effect of current application on the skin barrier.
Gratieri T; Kalia YN
Adv Drug Deliv Rev; 2013 Feb; 65(2):315-29. PubMed ID: 22626977
[TBL] [Abstract][Full Text] [Related]
5. Modeling the human skin barrier--towards a better understanding of dermal absorption.
Jepps OG; Dancik Y; Anissimov YG; Roberts MS
Adv Drug Deliv Rev; 2013 Feb; 65(2):152-68. PubMed ID: 22525516
[TBL] [Abstract][Full Text] [Related]
6. Potential of combined ultrasound and microneedles for enhanced transdermal drug permeation: a review.
Han T; Das DB
Eur J Pharm Biopharm; 2015 Jan; 89():312-28. PubMed ID: 25541440
[TBL] [Abstract][Full Text] [Related]
7. Microneedles for transdermal drug delivery.
Prausnitz MR
Adv Drug Deliv Rev; 2004 Mar; 56(5):581-7. PubMed ID: 15019747
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in microneedle-based drug delivery: Special emphasis on its use in paediatric population.
Duarah S; Sharma M; Wen J
Eur J Pharm Biopharm; 2019 Mar; 136():48-69. PubMed ID: 30633972
[TBL] [Abstract][Full Text] [Related]
9. Influencing factors and drug application of iontophoresis in transdermal drug delivery: an overview of recent progress.
Wang Y; Zeng L; Song W; Liu J
Drug Deliv Transl Res; 2022 Jan; 12(1):15-26. PubMed ID: 33486687
[TBL] [Abstract][Full Text] [Related]
10. Enhanced transdermal drug delivery techniques: an extensive review of patents.
Rizwan M; Aqil M; Talegaonkar S; Azeem A; Sultana Y; Ali A
Recent Pat Drug Deliv Formul; 2009 Jun; 3(2):105-24. PubMed ID: 19519571
[TBL] [Abstract][Full Text] [Related]
11. Microneedles: an emerging transdermal drug delivery system.
Bariya SH; Gohel MC; Mehta TA; Sharma OP
J Pharm Pharmacol; 2012 Jan; 64(1):11-29. PubMed ID: 22150668
[TBL] [Abstract][Full Text] [Related]
12. Next generation intra- and transdermal therapeutic systems: using non- and minimally-invasive technologies to increase drug delivery into and across the skin.
Gratieri T; Alberti I; Lapteva M; Kalia YN
Eur J Pharm Sci; 2013 Dec; 50(5):609-22. PubMed ID: 23567467
[TBL] [Abstract][Full Text] [Related]
13. Mathematical modelling of microneedle-mediated transdermal delivery of drug nanocarriers into skin tissue and circulatory system.
Newell B; Zhan W
J Control Release; 2023 Aug; 360():447-467. PubMed ID: 37429359
[TBL] [Abstract][Full Text] [Related]
14. Overcoming the skin permeation barrier: challenges and opportunities.
Vitorino C; Sousa J; Pais A
Curr Pharm Des; 2015; 21(20):2698-712. PubMed ID: 25925125
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and therapeutic applications of iontophoresis.
Sieg A; Wascotte V
J Drug Target; 2009 Nov; 17(9):690-700. PubMed ID: 19845485
[TBL] [Abstract][Full Text] [Related]
16. Passive and iontophoretic transport through the skin polar pathway.
Li SK; Peck KD
Skin Pharmacol Physiol; 2013; 26(4-6):243-53. PubMed ID: 23921111
[TBL] [Abstract][Full Text] [Related]
17. Future of the transdermal drug delivery market--have we barely touched the surface?
Watkinson AC; Kearney MC; Quinn HL; Courtenay AJ; Donnelly RF
Expert Opin Drug Deliv; 2016; 13(4):523-32. PubMed ID: 26646399
[TBL] [Abstract][Full Text] [Related]
18. Current Advancements in Transdermal Biosensing and Targeted Drug Delivery.
Pandey PC; Shukla S; Skoog SA; Boehm RD; Narayan RJ
Sensors (Basel); 2019 Feb; 19(5):. PubMed ID: 30823435
[TBL] [Abstract][Full Text] [Related]
19. Microneedles as transdermal delivery systems: combination with other enhancing strategies.
Nava-Arzaluz MG; Calderon-Lojero I; Quintanar-Guerrero D; Villalobos-Garcia R; Ganem-Quintanar A
Curr Drug Deliv; 2012 Jan; 9(1):57-73. PubMed ID: 21864254
[TBL] [Abstract][Full Text] [Related]
20. Iontophoretic drug delivery.
Kalia YN; Naik A; Garrison J; Guy RH
Adv Drug Deliv Rev; 2004 Mar; 56(5):619-58. PubMed ID: 15019750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
